Disruption of the plasminogen activator inhibitor‐1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice
- 27 June 2001
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 15 (10), 1840-1842
- https://doi.org/10.1096/fj.00-0750fje
Abstract
No abstract availableFunding Information
- Deutsche Forschungsgemeinschaft (#Scha 808/1-1)
This publication has 49 references indexed in Scilit:
- Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women with Polycystic Ovary SyndromeJournal of Clinical Endocrinology & Metabolism, 1997
- Polymerase Chain Reaction‐Restriction Fragment Length Polymorphisms (PCR‐RFLP) and Electrophoretic Assays for the Mouse Obese (Lepob) MutationObesity Research, 1997
- Elevation of plasminogen activator inhibitor 1 in borderline hypertension is linked to concomitant metabolic disturbancesEuropean Journal of Clinical Investigation, 1996
- Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide.JCI Insight, 1996
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.JCI Insight, 1995
- The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.JCI Insight, 1995
- Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistanceEndocrinology, 1994
- Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization.JCI Insight, 1993
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993
- In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp‐lpr/lpr mouseEuropean Journal of Immunology, 1990